Lung adenocarcinoma patient with EGFR 19 exon insert mutation and its response to icotinib

Lung Cancer. 2018 Jul:121:101-104. doi: 10.1016/j.lungcan.2018.04.019. Epub 2018 Apr 24.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / diagnosis*
  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / genetics
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Crown Ethers / therapeutic use*
  • Drug Resistance, Neoplasm / genetics
  • ErbB Receptors / genetics
  • Exons / genetics*
  • Humans
  • Lung Neoplasms / diagnosis*
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / genetics
  • Male
  • Mutation / genetics*
  • Quinazolines / therapeutic use*
  • Remission Induction

Substances

  • Antineoplastic Agents
  • Crown Ethers
  • Quinazolines
  • icotinib
  • EGFR protein, human
  • ErbB Receptors